Evaluation of chronic toxicity of cyclocreatine in beagle dogs after oral gavage administration for up to 23 weeksTOXICOLOGY AND APPLIED PHARMACOLOGYIF3.42021-11-013OAAI
Use of an animal model of disease for toxicology enables identification of a juvenile no observed adverse effect level for cyclocreatine in creatine transporter deficiencyREGULATORY TOXICOLOGY AND PHARMACOLOGYIF3.52021-07-012OAAI
Corroboration of Height Velocity Prediction Markers for rhGH With an Oral GH Secretagogue Treatment in Children With GHDJOURNAL OF THE ENDOCRINE SOCIETYIF3.12021-02-258OAAI
Development of a Predictive Enrichment Marker for the Oral GH Secretagogue LUM-201 in Pediatric Growth Hormone DeficiencyJOURNAL OF THE ENDOCRINE SOCIETYIF3.12021-02-2513OAAI
Evaluation of chronic toxicity of cyclocreatine, a creatine analog, in Sprague Dawley rat after oral gavage administration for up to 26 weeksREGULATORY TOXICOLOGY AND PHARMACOLOGYIF3.52020-11-016PREAI
Cyclocreatine treatment ameliorates the cognitive, autistic and epileptic phenotype in a mouse model of Creatine Transporter Deficiency环肌酸治疗可改善肌酸转运蛋白缺乏症小鼠模型的认知，自闭症和癫痫表型SCIENTIFIC REPORTSIF3.92020-10-2716OAAI
Translational control of gene expression in the gonadotropeMOLECULAR AND CELLULAR ENDOCRINOLOGYIF3.62014-03-0121OAAI
Polyribosome and ribonucleoprotein complex redistribution of mRNA induced by GnRH involves both EIF2AK3 and MAPKMOLECULAR AND CELLULAR ENDOCRINOLOGYIF3.62014-01-0111OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向